Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(33%)
Results Posted
100%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
5
83%
Ph phase_3
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(1)
Terminated(3)

Detailed Status

Withdrawn2
Recruiting2
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (16.7%)
N/A5 (83.3%)

Trials by Status

withdrawn233%
recruiting233%
terminated117%
completed117%

Recent Activity

2 active trials
Showing 5 of 6
recruitingnot_applicable

Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.

NCT05834803
recruitingnot_applicable

Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation

NCT05665608
withdrawnnot_applicable

Personalised Risk scOre For Implantation of Defibrillators in Patients With Preserved LVEF>35% and a High Risk for Sudden Cardiac Death

NCT04540289
withdrawnnot_applicable

Personalised Risk scOre For Implantation of Defibrillators in Patients With Reduced LVEF≤35% and a Low Risk for Sudden Cardiac Death

NCT04540354
completednot_applicable

Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses

NCT02328820
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05834803Not Applicable

Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.

Recruiting
NCT05665608Not Applicable

Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation

Recruiting
NCT04540289Not Applicable

Personalised Risk scOre For Implantation of Defibrillators in Patients With Preserved LVEF>35% and a High Risk for Sudden Cardiac Death

Withdrawn
NCT04540354Not Applicable

Personalised Risk scOre For Implantation of Defibrillators in Patients With Reduced LVEF≤35% and a Low Risk for Sudden Cardiac Death

Withdrawn
NCT02328820Not Applicable

Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses

Completed
NCT00608140Phase 3

Effectiveness of Surgical Mitral Valve Repair Versus Medical Treatment for People With Significant Mitral Regurgitation and Non-ischemic Congestive Heart Failure

Terminated

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6